Download the Agenda


Speaker Information

Grant Risdon Head of Corporate Development Agonox


Main Conference Day 2

2:50 PM Unlocking the Potential: The Future of Immune Checkpoint Therapy to Treat Cancer

• Immune checkpoint therapy has led to important clinical
advances and provided a new weapon against cancer
• The way forward for this class of novel agents lies in
the ability to understand human immune responses in the
tumor microenvironment
• Discover valuable information regarding the dynamic nature
of the immune response and regulation of additional
pathways that will need to be targeted through combination
therapies to provide survival benefit for greater numbers of
patients

Sponsorship Opportunities

Resource Center

Visit the Resource Center for complimentary industry related content!

IDGA

Become a Pharma IQ Member and receive our weekly newsletter!